The role of angiotensin II (Ang II) in skeletal muscle and satellite cell regulation is largely unknown. Cardiotoxin (CTX) was used in order to investigate whether muscle injury activates a local Ang II signaling system. Following injury, IHC analysis revealed a robust increase in the intensity of angiotensinogen and angiotensin type 1 (AT1) receptor expression. As regeneration proceeded, however, AT1 and angiotensinogen was downregulated. Nuclear accretion and fibre formation was also assessed during muscle regeneration in mice treated with captopril (an angiotensin converting enzyme
Introduction
The growth and maintenance of skeletal muscle is largely dependent on a population of myogenic progenitor cells commonly referred to as satellite cells (22) .
These cells are maintained in a state of quiescence under basal conditions, residing in the satellite cell niche between the basal lamina and sarcolemma (22) . In response to myotrauma osatellite cells activate, migrate to the site of injury, proliferate, and terminally differentiate (11) . It is now understood that adult myogenesis proceeds in a step wise fashion. During the first wave of differentiation, myoblasts fuse to one another in order to form new myotubes; during the second wave of differentiation, myoblasts fuse to nascent myotubes and promote their growth. (13, 14) .
The transition of a satellite cell from quiescence to terminal differentiation is referred to as the myogenic program and is orchestrated by a series of transcription factors known as the myogenic regulatory factors (Myf5, MyoD, MRF4 and myogenin), as well as the paired box transcription factor Pax7 (3). Though much is known about the function of these transcriptional factors, little is known regarding the cytokines and growth factors that serve to regulate their activity. We belive that one such growth factor may be Ang II.
We have recently described a local Ang II signaling system in cultured primary and C2C12 myoblasts (17) . The presence of this system was defined by the expression of a large number of Ang II signaling family members (17) . Furthermore, we also demonstrated that cultured C2C12 cells possess the ability to secrete both Angiotensin I and Ang II in vitro (17) . We have also demonstrated that inhibition of Ang II signaling (through captopril treatment or AT1a receptor ablation) impaired the growth of skeletal muscle following cardiotoxin (CTX)-induced injury (16) . Finally, we established that Ang II serves a function role in satellite cell regulation, inducing activation and promoting chemotaxis (16) . These findings are in agreement with other published works (7) (35) that have demonstrated that ACE inhibition significantly represses skeletal muscle hypertrophy, as evidenced by a decreases in total protein content, fibre cross-sectional area (CSA), and myonuclear accretion by new muscle fibers.
Although we have described a role for Ang II in regulating the early response of satellite cells to muscle injury, Ang II may also play an important role in other satellite cell processes. Indeed, Ang II has been implicated in the regulation of numerous cellular functions such as cell proliferation, protein synthesis (15, 20) , protein degradation (39) and cell survival (27) . In this study we further define skeletal muscle as possessing a local Ang II signaling system and demonstrate that it functions to regulate myonuclear accretion and myofiber hyperplasia following severe myotrauma.
These results further support the capacity for Ang II to act as a pleiotropic factor in skeletal muscle.
Materials and Methods
Animals/experimental procedures. Data were generated from two separate time-course experiments using ten-week-old C57Bl/6 male mice (Jackson laboratories, USA). The first experiment (n=5 per group) was designed to describe the effect of muscle regeneration on the activation pattern of a local Ang II signaling system. Animals were subjected to bilateral injections of CTX (25µl at 10µM) into their TA muscle. The second experiment (n=10 per group) was designed to assess the role of Ang II in regulating skeletal muscle fibre formation and myonuclear accretion. Animals were supplemented with either normal drinking water or captopril (0.5mg/mL, Sigma, Canada) treated drinking water three days prior to and throughout the experimental protocol. The protocol consisted of bilateral injections of CTX (25µl at 10µM) into the TA muscle.
Tissues for experiment 1 were harvested 7, 14 and 21 days (exp1) and tissues for experiment 2 were harvested 10 and 21 days post injection. Also, for reference of normal skeletal muscle architecture, muscle fibre number, and basal renin angiotensin system (RAS) member protein expression, a non-injured, non-supplemented group (n=8) was included. Mice were handled daily by the same investigator and fed ad libitum. Captopril was dissolved in the drinking water; water consumption was monitored daily and did not differ between groups. All procedures were conducted Histology. TAs were excised and fixed in neutral buffered formalin, embedded in paraffin, and stained with hematoxylin and eosin (H&E) to reveal skeletal muscle architecture. Stains were viewed on a Nikon Eclipse 90i and analyzed using the Nikon NIS Elements 3.0 software (Nikon Instruments, Inc., USA). The number of nuclei per muscle fibre was calculated using no less than 300 fibres. Additionally, the total number and density of fibers (fibers/mm 2 ) was analyzed at 10 and 21d post injury in the TA muscle.
RNA isolation, reverse transcription and quantitative real-time polymerase chain
reaction. RNA was isolated from the TA of control and captopril treated mice 10, and 21d post CTX injection using the Trizol/RNeasy method (Qiagen Sciences, Montreal, Canada), reverse transcribed using a commercially available kit (Applied Biosystems High Capacity cDNA Reverse Transcription Kit; Applied Biosystems, USA) and analyzed using quantitative RT-PCR (qRT-PCR) using methods previously described in detail (23) . Gene expression fold change was calculated using the delta-delta Ct method (21) . Ribosomal protein L32 was used as a housekeeping gene as its expression was not different between control and captopril treated groups. Primer sequences and annealing temperatures can be found in Table 1 . Statistical Analysis. The number of nuclei/fibre, fibre density, and total number of muscle fibres per TA were calculated by two-way analysis of variance (ANOVA). The number of myogenin+ and Pax7+ cells per 100 fibres, as well as all PCR analysis, were compared between groups by t-test. Significance was accepted at p<0.05.
Results

CTX-induced injury activates a local skeletal muscle angiotensin signaling system.
We previously demonstrated that, in vitro, skeletal muscle myoblasts and myotubes possess a local angiotensin signaling system and the ability to produce Ang II (17) .
Therefore, we assessed the response of components of this local system to muscle damage in vivo using IHC. Under basal conditions AT1 and angiotensin (panangiotensin antibody) displayed weak, diffuse staining suggesting low protein expression (Fig 1A, C) . However, 7 days following injury, robust staining of angiotensin and AT1 was observed in newly regenerated fibers (fibers displaying central nuclei), demonstrating a clear activation of this system (Fig 1B, D) . Interestingly, as regeneration proceeded, AT1 was downregulated, resulting in a mosaic staining pattern whereby some fibres remained strongly positive while others appeared completely negative for AT1 (Fig 1E, F) . These results indicate that Ang II signaling through AT1 may play a role in the regenerative response to muscle injury.
Captopril treatment inhibits myonuclear accretion and induces hyperplasia. Based on
the IHC results, and our previous findings that inhibition of Ang II signaling resulted in decreased myofibre size following injury, (16), we then investigated the role of Ang II signaling in the formation of new fibres and the accretion of nuclei into myofibres during regeneration. Analysis of H&E stained cross-sections demonstrated that, when compared to controls, ACE inhibition significantly reduced the myonuclei/fibre ratio by 28%, 21d following CTX injury (Fig. 2C ). No differences were observed 10d following injury (data not shown). Interestingly, when the total number of myofibres per TA was analyzed, it was discovered that captopril treatment also induced substantial hyperplasia with a 37% increase in total fibre number compared to controls (p<0.05, Fig.   2D ) 21d following injury while no differences were observed 10d following injury (data not shown). This also translated into a 56% increased density of myofibres/mm 2 ( Fig.   2E ). Therefore, while controls appeared to reach a plateau in fibre number by 10d, the captopril treated mice continued to form myofibres until day 21. Interestingly, due to this robust increase in fibre content the absolute estimated number of nuclei within the cross-section (by calculating the nuclei per fibre multiplied by the total number of fibres) may not have been different between groups 21d post injury (con-9214.8 ± 1352.4, cap-9938.6 ± 284.3, p=0.6). Since the loss of the TGFβ family member myostatin has been strongly implicated in the hyperplasia of skeletal muscle fibres (8, 10, 25) , we assessed the mRNA expression of myostatin related genes including myostatin, follistatin, activin IIb receptor and follistain-like protein-3. Surprisingly, with the exception of a trend for a decrease in the activin IIb receptor with captopril treatment 21d post injection (p=0.067), no significant differences were observed in the expression of the genes analyzed between groups (data not shown). Although these data are not definitive, they indicate that Ang II may regulate muscle cell number through mechanisms independent of myostatin and myostatin related proteins. Collectively, these results indicate that a lack of Ang II signaling during muscle regeneration resulted in the de novo synthesis of additional myofibres that contained fewer myonuclei, likely through mechanisms independent of myostain signaling.
Blockade of Ang II production alters MRF gene expression. The formation and growth of myofibres following injury is dependent on appropriate function of the satellite cell pool, including adequate expansion, efficient differentiation, and the subsequent growth of de novo fibres (11) . Therefore, we assessed the mRNA expression of the MRFs and the content of satellite cells 10 and 21d following CTX injury in control and captopril treated mice. 10 days following injury, captopril treatment appeared to retain the expression of satellite cell proliferative markers with significant 1.7 and 1.9 fold increases in Myf5 and Pax7 (Fig. 3A, B) , respectively, while repressing the expression of markers of differentiation (myogenin -2.9 fold decrease; p<0.05, Fig. 3D ). We believe this gene expression profile is indicative of delayed differentiation in the captopril treated animals.
ACE inhibition decreases satellite cell content following CTX-induced injury.
We performed IHC staining of satellite cells to assess the effect of captopril treatment on muscle satellite cell content. Although no significant differences were observed in total satellite cell content (Pax7 + cells, Con -12.1±1.2, Cap-11.7±1.5 Pax7+ cells/100 fibres; p=0.9), a strong trend (p=0.063) for a reduction in the proportion of myogenin + (differentiating) myoblasts was evident in the captopril treated animals 10d post CTX injection (Fig. 4C) in agreement with the myogenin expression analysis. To lend further support to the idea that captopril treatment induced delayed differentiation we assessed the expression of the embryonic isoform of myosin heavy chain (eMHC), which becomes rapidly downregulated upon fibre maturation and is only expressed in newly formed fibers (4) . qRT-PCR analysis revealed a significant 3.5-fold higher expression of eMHC in the captopril treated as compared to the controls (Fig. 3E) 
Discussion
The current data demonstrate that skeletal muscle possesses a local Ang II signaling system that functions in vivo to regulate muscle fibre formation, myonuclear addition, and fibre maturation during muscle regeneration. The myogenic effects of Ang II appear to be related to regulation of satellite cell differentiation. These findings implicate Ang II as a pleiotropic growth factor in skeletal muscle, with functions separate and independent of its classical role as a regulator of blood pressure and fluid homeostasis. We have previously reported that isolated primary and C2C12 myoblasts and myotubes express a local Ang II signaling system that is responsive to mechanical stimulation (17) . We extend these findings by reporting that injection of CTX, and the subsequent regenerative response, activate key members of this local RAS. We report an increased production of angiotensinogen, and/or its metabolites, at the onset of regeneration using IHC. The absence of angiotensinogen in uninjured muscle followed by a robust upregulation and progressive downregulation over time suggests that the intramuscular angiotensin signaling system is not constitutively active under basal conditions and requires an appropriate cue for activation. This notion was further supported by the observation that the AT1 receptor shared the same temporal expression pattern as pan-angiotensin following injury. An intriguing observation was that the mosaic staining pattern of AT1 observed 21 days following injury was similar to that of a fibre-type distribution stain. Regrettably, technical complications (formalin fixation) precluded our ability to perform a fibre-type analysis; however, AT1 fibre-type specificity remains an important question that requires further investigation.
Interestingly, the activation pattern of both angiotensin and AT1 were similar with the most intense staining patterns observed early during the synthesis of new fibres. At this time, the regulatory relationship between skeletal muscle angiotensin and AT1 expression is currently unknown but it is possible that feed-forward mechanisms may drive the increased production of Ang II to further aid in the regenerative response.
Indeed, feed-forward mechanisms have been described in hepatocytes, whereby Ang II induces nuclear factor-Κ B signaling and subsequent angiotensinogen promoter activity and transcription (19) . Further examination of the relationship between AT1/Ang II expression, fibre-type specificity, nuclear content, degree of repair and intracellular signaling during an extended regenerative timecourse is warranted.
Previous in vitro observations identified Ang II as a potent chemotactic agent (16) . We therefore hypothesized that the increased production of angiotensin during regeneration serves, at least in part, to act as a migratory stimulus that attracts myoblasts to fuse with growing fibres. Since the growth of skeletal muscle is partially contingent upon the addition of new nuclei to the myofibre (12), we assessed the effect of ACE inhibition on nuclear addition as well as myofibre formation and satellite cell function. Our experiments clearly demonstrate that Ang II is necessary for normal myonuclear accretion during muscle regeneration. These results are in agreement with Westerkamp and colleagues who demonstrated, using a synergist model of overload induced hypertrophy (35) , that ACE inhibition resulted in the inability to add new nuclei to the soleus muscle. Though our data demonstrate that captopril treatment repressed myonuclear addition to individual fibres, it is interesting to note that the estimated number of nuclei per cross section remained unaltered due to increased myofiber formation. When the density of myonuclei (per nm) is calculated in section there are no significant differences observed between control and captopril treated mice (2.52 ± 0.186 and 2.63 ± 0.145, respectively). As total nuclear content remains the same we conclude that ACE inhibition does not prevent myonuclear addition, it simply redistributes it to a larger complement of fibers.
These findings highlight the function of ACE as a focal point of regulation on skeletal muscle size and nuclear content. Along these lines, recent investigations have identified a polymorphism of a 287-base-pair insertion (I) in the ACE gene. Absence of this insertion (deletion -(D)) was associated with higher plasma ACE activity (28) .
Associations between the ACE genotype and physical performance have been observed: homozygous expression of the D allele is correlated with enhanced trainingrelated strength gains while homozygous expression of the I allele has been linked with improved endurance performance (18, 36) . Although these reports remain highly controversial, they identify ACE as one of the few known genetic polymorphisms linked to physical performance. Uncovering the exact functions of Ang II in regulating human skeletal muscle growth and repair is an exciting area that warrants further investigation. Perhaps most surprisingly, captopril treatment resulted in a significant increase in the total number of fibres in the TA 21 days after injury. Though skeletal muscle fiber hyperplasia has been previously observed using load-induced stretch of avian skeletal muscle, (1, 2) as well as strength training of cats (5, 6) and rodents (32) , no reports exist documenting the induction of hyperplasia following severe injury. To our knowledge this is the first report describing the induction of hyperplasia due to captopril treatment following CTX-induced injury. The functional significance and cellular and molecular mechanisms underlying captopril-induced hyperplasia is currently unknown.
However, it is conceivable that the previous observations of repressed myoblast chemotaxis due to inhibited Ang II signaling (16) , and the impaired cell differentiation observed in the present study, could collectively result in hyperplasia. Alternatively, Ang II may not directly impact myoblast differentiation per se; the deficiency in myoblast fusion may ultimately be a consequence of the lack of Ang II induced migration (16) .
For example, if myoblasts are unable to efficiently migrate and fuse with new myofibres, it is plausible that aberrant cell to cell fusion could occur resulting in the synthesis of more fibres. This hypothesis is in agreement with our in vivo IHC staining demonstrating the increased production of angiotensin following injury. We propose that Ang II may serve as the chemotactic signal directing the differentiation of myoblasts and allowing the subsequent growth of myofibres. This is also in line with results suggesting that the total estimated number of myonuclei within the cross section was not different between groups 21d post injection; similar numbers of myoblasts in each group ultimately underwent terminal differentiation. Although hyperplasia may be seen as a potentially beneficial adaptation, it should be considered that under the current experimental conditions hyperplasia was accompanied by an inability to add nuclei to existing fibres, an inhibited maturation of newly formed myofibres, and a disrupted satellite cell response. As our study design only monitored regeneration until 21 days it is unknown if this captopril induced hyperplasia is a persistent phenotype or one that will fade with time. The functional relevance of this observation is unclear at this time.
Clinically, ACE inhibitors and angiotensin receptor blockers (ARBs) are amongst the most commonly prescribed antihypertensive medications (9), particularly amongst older adults. Although generally considered safe, few studies have examined the direct effects of ACE inhibitors or ARBs on skeletal muscle function, adaptation to exercise, and muscle regeneration in humans. This is a particularly relevant issue given that the majority of individuals on these drugs are already at risk of skeletal muscle loss as a result of aging. Delineating all potential secondary effects of these widely prescribed pharmaceuticals in "non-significant" tissues such as skeletal muscle is an important endeavor In summary, the current investigation provides evidence that the activation of a local Ang II signaling system is an important component of skeletal muscle fibre formation and nuclear accretion following CTX-induced injury. This local system functions to regulate the differentiation of muscle satellite cells and maturation of new myofibres. Tables   Table 1.   Gene  Forward primer  Reverse primer  Annealing Temp  Myf5  TGAAGGATGGACATGACGGACG TTGTGTGCTCCGAAGGCTGCTA  59°C  MyoD  TACCCAAGGTGGAGATCCTG  CATCATGCCATCAGAGCAGT  59°C  Myogenin CTACAGGCCTTGCTCAGCTC  AGATTGTGGGCGTCTGTAGG  59°C  Pax7  CTGGATGAGGGCTCAGATGT  GGTTAGCTCCTGCCTGCTTA  59°C  eMHC  AAAAGGCCATCACTGACGC  CAGCTCTCTGATCCGTGTCTC  60°C  L32 TCCACAATGTCAAGGAGCTG ACTCATTTTCTTCGCTGCGT 59°C
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